Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fairfax Declares Annual Dividend
-
Sify Technologies to announce Financial Results for Third Quarter FY 2025-26 on Monday, January 12, 2026
-
Form 8.3 - [IDOX PLC - 02 01 2026] - (CGWL)
-
Entente Education Canada launches new name, new leadership and bold new direction
-
Form 8.3 - [IQE PLC - 02 01 2026] - (CGAML)
-
Baker Hughes Closes Sale of Precision, Sensors & Instrumentation Product Line to Crane Company
-
Baker Hughes Closes Sale of Precision, Sensors & Instrumentation Product Line to Crane Company
-
ParaZero Successfully Completes DefendAir Live Demonstration for Senior NATO Officers
-
ParaZero Successfully Completes DefendAir Live Demonstration for Senior NATO Officers
-
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH
-
Enviri Announces Chief Financial Officer Tom Vadaketh’s Retirement and Plans to Appoint Pete Minan as New Enviri CFO
-
SAGA Metals Reports Strongest Critical Mineral Drill Results To-Date at Radar Ti-V-Fe Project in Labrador
-
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
-
Copperhead Resources Announces Changes in Officers
-
3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position
-
Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis
-
ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors
-
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY’S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Validic Powers Scalable AI-Driven Remote Care at CES 2026
-
3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position
-
Advanced Flower Capital Completes Conversion to Business Development Company
-
AMC Robotics Establishes Vietnam Subsidiary to Expand Local Partnerships and Support Robotics Manufacturing
-
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
-
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
-
MiniLuxe Announces Approval of Amendments to Equity Incentive Plan
-
Allot to Present at the Needham Growth Conference on January 14, 2026
-
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
-
MEDIA ADVISORY: Sixth Anniversary Commemoration of the Downing of Flight PS752
-
Prospect Credit REIT Achieves 13.35% Annualized Total Return Versus 6.28% Stanger-Tracked Non-Traded REIT Average Through Q3 2025
-
Tango Therapeutics Appoints Sung Lee to Board of Directors
-
Alta Equipment Group Announces Preferred Stock Dividend
-
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
-
Lantronix Previews Turnkey Drone Reference Platform to Accelerate Defense and Commercial UAV Development
-
Beneficient Regains Full Compliance with Nasdaq Listing Requirements
-
Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project
-
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer
-
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
-
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
-
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Evergold Announces $300,000 Ore Group Financing, Sharpened Focus on Golden Lion Project, Toodoggone District, Northern BC
-
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morg
-
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
-
Mobilicom Announces New Design Win and Initial Order from United Arab Emirates–Based Arms Manufacturer
-
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
-
Mobix Labs Powers Up U.S. Defense Operations: Veteran Defense GM Takes the Helm; Bigger Military-Approved Facility Expansion Planned
-
Beamr 2026 Strategy and 2025 Highlights
-
UMH PROPERTIES, INC. FOURTH QUARTER AND FULL YEAR 2025 OPERATIONS UPDATE
